真奥药业集团有限公司

Chinese pharmaceutical group established on 8 November 2016 and headquartered in the biomedical industrial park of the Xian'an economic development zone in Xianning, Hubei. Covers chemical drug formulation manufacturing, traditional Chinese medicine decoction piece processing and finished TCM production, medicinal plant cultivation and trading, sanitary products, pharmaceutical R&D and medical consulting. Runs five manufacturing companies with more than thirty production lines and over three hundred drug approval numbers; its core subsidiary Zhen'ao Honeysuckle Pharmaceutical makes honeysuckle oral liquid, tetracaine hydrochloride gel, indapamide sustained-release tablets and Zhiqi granules. Recognised as a national high-tech enterprise, a national green factory and a Hubei specialised little-giant enterprise, with 1.29 billion yuan of revenue in 2024.